Dudediligence.

Achieve Life Sciences, Inc

ACHVNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$12.5MSep ’24−$12.4MDec ’24−$12.8MMar ’25−$12.7MJun ’25−$14.4MSep ’25−$14.7MDec ’25−$10.2MMar ’26−$74.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Net income−$33.2M−$42.4M−$29.8M−$39.8M−$54.6M
Operating cash flow−$29.4M−$37.6M−$24.5M−$29.8M−$49.5M
Free cash flownone on filenone on file−$24.5Mnone on file−$49.5M
Cash$43.0M$24.8M$15.5M$12.8M$20.9M
Shares outstanding9.5M17.9M21.2M34.7M53.2M